Showing results (1451-1460 of 2,631) with videos related to
Sort By:
Pageof 264
Journal of Oncology|June 13, 2012
Lycopene, Tomato Products, and Prostate Cancer Incidence: A Review and Reassessment in the PSA Screening EraMelissa Y Wei, Edward L GiovannucciJournal of Oncology|June 13, 2012
Cucurbitacin B Causes Increased Radiation Sensitivity of Human Breast Cancer Cells via G2/M Cell Cycle ArrestSuwit Duangmano, Phorntip Sae-Lim, Apichart Suksamrarn, et al.Journal of Oncology|October 21, 2009
A Case Report of Intraductal Papillary-Mucinous Neoplasm of the Pancreas Showing Morphologic Transformation during Followup PeriodsYuichi Sanada, Shinji Osada, Yoshihiro Tanaka, et al.Journal of Oncology|January 7, 2010
Histone deacetylase inhibitor therapy in epithelial ovarian cancerNoriyuki Takai, Hisashi NaraharaJournal of Oncology|January 6, 2010
Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck CancerBiljana Culjkovic, Katherine L BordenJournal of Oncology|January 6, 2010
The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian CancerLilian T Gien, Helen J MackayJournal of Oncology|January 14, 2010
Rare and challenging tumor entity: phyllodes tumor of the prostateAndreas Bannowsky, Andreas Probst, Helmut Dunker, et al.Journal of Oncology|January 12, 2019
Transforming of the Tumor Microenvironment: Implications for TGF-β Inhibition in the Context of Immune-Checkpoint TherapyStefanie LöffekJournal of Oncology|November 28, 2019
The Cancer Microbiota: EMT and Inflammation as Shared Molecular Mechanisms Associated with Plasticity and ProgressionDaniele Vergara, Pasquale Simeone, Marina Damato, et al.Journal of Oncology|November 28, 2019
Esophageal Cancer: Should Gender Be Considered as an Influential Factor for Patient Safety in Drug Treatment?Fengxia Liu, Helin Feng, Sumin Guo, et al.Pageof 264